XXEC Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-70,532
Closed -$5.48M 28
2022
Q4
$5.48M Buy
70,532
+176
+0.3% +$14.3K 4.4% 10
2022
Q3
$5.68M Sell
70,356
-1,371
-2% -$123K 4.89% 9
2022
Q2
$6.44M Sell
71,727
-2,886
-4% -$292K 5.13% 10
2022
Q1
$8.38M Sell
74,613
-335
-0.4% -$35.4K 5.83% 6
2021
Q4
$7.81M Buy
74,948
+26,905
+56% +$3.12M 6.66% 5
2021
Q3
$6.02M Sell
48,043
-905
-2% -$117K 4.58% 8
2021
Q2
$6.08M Buy
48,948
+615
+1% +$77.2K 4.02% 10
2021
Q1
$5.71M Buy
48,333
+18
+0% +$2.11K 4.02% 11
2020
Q4
$5.66M Buy
+48,315
New +$5.32M 4.45% 7

Other funds holding MDT

XXEC Inc's MDT Position: Q1 2023 in Review

XXEC Inc sold out of Medtronic (MDT) in Q1 2023, closing a stake of 70,532 shares — an estimated $5.48M sold.

XXEC Inc first reported a position in MDT in Q4 2020 and held it in 9 quarters. The position peaked at $8.38M in Q1 2022. 1,991 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • XXEC Inc reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • XXEC Inc sold 70,532 Medtronic shares in Q1 2023, an estimated $5.48M.
  • XXEC Inc first reported a position in Medtronic in Q4 2020 and held it in 9 quarters.
  • XXEC Inc's Medtronic position peaked at $8.38M in Q1 2022.
  • 1,991 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on XXEC Inc's 13F filing for Q1 2023, filed 8 May 2023.